Greystone Associates

Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Transdermal drug delivery patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Growth is being driven by several factors – factors with strong demographic and population trend underpinnings. Transdermal patch developers are expanding the type and number of prescription and OTC therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. The ecosystem that supplies patch manufacturing and testing services is an important factor in the development of new transdermal patches. The report is structured to provide transdermal drug delivery sector participants with all of the information necessary to identify marketing factors and business opportunities for transdermal drug delivery products.

Publication Date: August 2009

Summary of Contents (see Prospectus for full Contents)

Executive Summary

The Evolving Drug Delivery Marketplace

Factors Favoring Non-traditional Routes of Administration

Transdermal Delivery Demand Drivers

Factors Limiting Growth

Competitive Landscape

Key Forecasts

Transdermal Drug Delivery Dynamics

Passive Patches

Patch Design & Technology

Patch Construction

Patch Economics

Sourcing and Contract Manufacturing

Patch Manufacturer Profiles

Transdermal Gels

Formulation Technology

IP and Proprietary Technologies

Limitations of Transdermal Gels

Active Transdermal Delivery

Active Transdermal Technology

Electrical Current

Iontophoresis

Electroporation

Microporation

Laser Ablation

Mechanical Microneedle Arrays

Radio Frequency

Thermal/Heat

Ultrasound/Sonophoresis

Transdermal Delivery Therapeutic Markets – Analysis and Market Data

Contraception

Cardiovascular

Hormone Replacement Therapy

Local Anesthesia

Neurology

Osteoporosis

Pain Management

Urology

Emerging Patch Therapeutics – Opportunity and Risk Assessment

Addiction

Antiviral

Asthma

Diabetes

Neurology

Oncology

Reproductive Medicine

Sexual Dysfunction

Vaccines

Profiles of Marketed Transdermal Products

Profiles of Products in Development for Delivery via Transdermal Systems

Market Factors

FDA Regulations

Rx-to-OTC Switching

New Patch Technologies

Skin Patch Revenue Models

Market Participant Profiles (40 Companies Profiled)

TABLES & CHARTS

(See Prospectus for Details)

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.